SOLUTIONS
Delivering RNA-based solutions for your
disease early interception journey
Delivering RNA-based solutions for your disease early interception journey
Preventing Cancer Deaths Through Early Detection
We are saving lives with our flagship product, GASTROClear, the world’s first molecular blood test for early detection of gastric (stomach) cancer, the 4th deadliest cancer globally.
We are developing a multi-cancer screening test.
COVID-19 Response and Opportunities
We leveraged our expertise in RNA and PCR productization infrastructure to mass produce Singapore’s first and one of world’s first ten COVID-19 PCR tests.
Today, we offer a comprehensive range of infectious disease testing solutions.
Open Access to Personalized Testing
We seek to provide timely, actionable, and personalized insights to guide clinical decisions for every step of the patient journey
We are partnering healthcare institutions and payers to expand patient access to precision oncology testing services.
SOCIAL MEDIA
- Genomics
- Clinical Sequencing
- Research Sequencing
- Cancer Screening
- GASTROClear for Patients
- GASTROClear for Medical Professionals
- LUNGClear
- Cancer Treatment Selection
- APEX Tissue Panel for Medical Professionals
- Infectious Diseases
- Fortitude 2.1
- Fortitude 3.0
- Fortitude Syndromic Panel
- CoVClear Mutation Panel
- Swab & Saliva Collection
- RNA Extraction Kit & Instruments